BRCA2 and Hodgkins lymphoma: In a recent study, we demonstrated that germline pathogenic variants in BRCA2 are associated with risk of pediatric or adolescent non-HL.20 Here, we followed a similar paradigm to leverage genetic data of HL survivors to identify new genetic variants in HLA and non-HLA regions that are associated with the risk of childhood-onset HL.